Development and validation of HPLC method for analysis of indolocarbazole derivative LCS-1269
Indolocarbazole glycosidic derivative LCS-1269 with significant antiproliferative activity has been synthesized in N.N. Blokhin National Medical Research Center of Oncology. To control the quality of the substance, the chromatographic method of the assay was created and validated. The technique was...
主要な著者: | Zoya Shprakh, Andrei Budko, Dmitry Kozin, Lydia Ektova, Dmitry Gusev, Vladimir Reshetnyak, Olga Nesterova |
---|---|
フォーマット: | 論文 |
言語: | English |
出版事項: |
Pensoft Publishers
2021-05-01
|
シリーズ: | Pharmacia |
オンライン・アクセス: | https://pharmacia.pensoft.net/article/63457/download/pdf/ |
類似資料
-
Molecular Mechanisms of Anticancer Activity of N-Glycosides of Indolocarbazoles LCS-1208 and LCS-1269
著者:: Roman G. Zenkov, 等
出版事項: (2021-12-01) -
Standardization of the Pharmaceutical Substance of the Drug LCS-1208
著者:: E. V. Ignateva, 等
出版事項: (2021-08-01) -
A new indolocarbazole derivative in melanoma and carcinoma lung in vivo treatment
著者:: Anna Lantsova, 等
出版事項: (2021-04-01) -
Application of Solid Dispersion Technology to Obtain a Model of Injectable Dosage Form of Indolocarbazole Derivative
著者:: A. P. Kolpaksidi, 等
出版事項: (2022-11-01) -
ANTITUMOR DRUGS BASED ON INDOLOCARBAZOL DERIVATIVES
著者:: I. P. Kolpaksidi, 等
出版事項: (2021-09-01)